Sahebkar A - Search Results

1

Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics.

Liu Z, Ma X, Ilyas I, Zheng X, Luo S, Little PJ, Kamato D, Sahebkar A, Wu W, Weng J, Xu S. Liu Z, et al. Among authors: sahebkar a. Theranostics. 2021 Mar 4;11(9):4502-4515. doi: 10.7150/thno.54498. eCollection 2021. Theranostics. 2021. PMID: 33754074 Free PMC article. Review.

2

Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways.

Yaribeygi H, Butler AE, Atkin SL, Katsiki N, Sahebkar A. Yaribeygi H, et al. Among authors: sahebkar a. J Cell Physiol. 2018 Jan;234(1):223-230. doi: 10.1002/jcp.26851. Epub 2018 Aug 4. J Cell Physiol. 2018. PMID: 30076706 Review.

3

Sodium-glucose cotransporter inhibitors and oxidative stress: An update.

Yaribeygi H, Atkin SL, Butler AE, Sahebkar A. Yaribeygi H, et al. Among authors: sahebkar a. J Cell Physiol. 2019 Apr;234(4):3231-3237. doi: 10.1002/jcp.26760. Epub 2018 Nov 15. J Cell Physiol. 2019. PMID: 30443936 Review.

4

A response to "In response to 'Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways'".

Yaribeygi H, Katsiki N, Butler AE, Atkin SL, Sahebkar A. Yaribeygi H, et al. Among authors: sahebkar a. J Cell Physiol. 2019 Jul;234(7):9908-9909. doi: 10.1002/jcp.28041. Epub 2019 Feb 2. J Cell Physiol. 2019. PMID: 30710347 No abstract available.

5

Mechanistic effects of SGLT2 inhibition on blood pressure in diabetes.

Yaribeygi H, Atkin SL, Sahebkar A. Yaribeygi H, et al. Among authors: sahebkar a. Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1679-1683. doi: 10.1016/j.dsx.2019.03.031. Epub 2019 Mar 17. Diabetes Metab Syndr. 2019. PMID: 31336541 Review.

6

Natural products with SGLT2 inhibitory activity: Possibilities of application for the treatment of diabetes.

Moradi-Marjaneh R, Paseban M, Sahebkar A. Moradi-Marjaneh R, et al. Among authors: sahebkar a. Phytother Res. 2019 Oct;33(10):2518-2530. doi: 10.1002/ptr.6421. Epub 2019 Jul 29. Phytother Res. 2019. PMID: 31359514 Review.

7

A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome.

Kiaie N, Gorabi AM, Penson PE, Watts G, Johnston TP, Banach M, Sahebkar A. Kiaie N, et al. Among authors: sahebkar a. Drug Discov Today. 2020 Jan;25(1):58-72. doi: 10.1016/j.drudis.2019.09.005. Epub 2019 Sep 13. Drug Discov Today. 2020. PMID: 31525463 Review.

8

A Review on the Effects of New Anti-Diabetic Drugs on Platelet Function.

Yaribeygi H, Atkin SL, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: sahebkar a. Endocr Metab Immune Disord Drug Targets. 2020;20(3):328-334. doi: 10.2174/1871530319666191014110414. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31612835 Review.

9

Molecular mechanisms by which SGLT2 inhibitors can induce insulin sensitivity in diabetic milieu: A mechanistic review.

Yaribeygi H, Sathyapalan T, Maleki M, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: sahebkar a. Life Sci. 2020 Jan 1;240:117090. doi: 10.1016/j.lfs.2019.117090. Epub 2019 Nov 22. Life Sci. 2020. PMID: 31765648 Review.

10

Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus.

Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Yaribeygi H, et al. Among authors: sahebkar a. Oxid Med Cell Longev. 2020 Mar 9;2020:8609213. doi: 10.1155/2020/8609213. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32215179 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,851 results

Search Page